Stanford University

Total Awards: 
89
Award Value: 
$297,368,420
Major Facility Name: 
Lorry I. Lokey Stem Cell Research Building
Institution type: 
Not for profit

Awards to the Institution

Award Value
Disease Team Research I: Gary Steinberg Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke $20,000,000
Early Translational II: Michele Calos Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,900
Basic Biology IV: Gerald Crabtree Mechanism and Utility of Direct Neuronal Conversion with a MicroRNA-Chromatin Switch $1,392,426
Basic Biology IV: Michelle Monje Stem Cell Mechanisms Governing Discrete Waves of Gliogenesis in the Childhood Brain $1,264,248
Basic Biology IV: Alexander Dunn Role of mechanical signaling in stem cell self-renewal and differentiation $1,064,224
Basic Biology IV: Michael Cleary Prostaglandin pathway regulation of self-renwal in hematopoietic and leukemia stem cells $1,244,455
Basic Biology IV: Anne Brunet Energy metabolism and aging pathways in human stem cell reprogramming and differentiation $1,414,044
Basic Biology IV: Roel Nusse Asymmetric stem cell division oriented by a local self-renewing signal $1,039,058
New Faculty II: Ching-Pin Chang VEGF signaling in adventitial stem cells in vascular physiology and disease $3,008,076
Basic Biology IV: Ben Barres Phenotyping Human Astrocytes in Health and Disease $0
Basic Biology IV: Howard Chang Long noncoding RNAs for pluripotency and cell fate commitment $1,386,627
Transplantation Immunology: Robert Negrin Regulatory T cell induced tolerance to ESC transplantation $1,383,147
Basic Biology III: Michael Clarke USP16 controls stem cell number: implications for Down Syndrome $1,264,032
Basic Biology III: Aaron Hsueh Correlated time-lapse imaging and single cell molecular analysis of human embryo development $1,260,122
Basic Biology III: Joanna Wysocka Enhancer-mediated gene regulation during early human embryonic development $1,425,600
Basic Biology III: Sean Wu Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells $1,264,248
Comprehensive Grant: Stefan Heller Generation of inner ear sensory cells from human ES cells toward a cure for deafness $2,330,559
Comprehensive Grant: Roel Nusse Guiding the developmental program of human embryonic stem cells by isolated Wnt factors $1,710,817
Comprehensive Grant: Julie Baker Functional Genomic Analysis of Chemically Defined Human Embryonic Stem Cell $2,518,303
Comprehensive Grant: Theo Palmer Immunology of neural stem cell fate and function $2,396,000
Comprehensive Grant: Christopher Zarins Engineering a Cardiovascular Tissue Graft from Human Embryonic Stem Cells $2,454,490
Comprehensive Grant: Renee Reijo Pera Human oocyte development for genetic, pharmacological and reprogramming applications $2,298,411
Early Translational I: Michael Longaker Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Transplantation Immunology: Christopher Contag Engineering Embryonic Stem Cell Allografts for Operational Tolerance $1,411,588
Transplantation Immunology: Judith Shizuru Purified allogeneic hematopoietic stem cells as a platform for tolerance induction $1,233,275
Transplantation Immunology: Kenneth Weinberg “Engineered immune tolerance by Stem Cell-derived thymic regeneration” $1,289,195
Basic Biology I: Susan McConnell Identification and characterization of human ES-derived DA neuronal subtypes $1,404,853
Comprehensive Grant: Irving Weissman Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells $2,471,386
SEED Grant: Julien Sage Functions of RB family proteins in human embryonic stem cells $498,609
Basic Biology I: Julien Sage The retinoblastoma (RB) gene family in cellular reprogramming $1,363,171
SEED Grant: Krishna Shenoy Technology for hESC-Derived Cardiomyocyte Differentiation and Optimization of Graft-Host Integration in Adult Myocardium $572,891
New Cell Lines: Renee Reijo Pera Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype $1,409,441
New Cell Lines: Michael Longaker Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts $1,406,636
New Cell Lines: Michele Calos Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses $1,406,875
New Cell Lines: Julie Baker Derivation of hESC Lines with Disease Lesions $1,404,725
Basic Biology II: Aaron Hsueh Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation $1,309,018
Basic Biology II: Garry Nolan Kinase signaling analysis of iPS cell reprogramming and differentiation $1,343,789
Basic Biology II: Steven Artandi Self-renewal and senescence in iPS cells derived from patients with a stem cell disease $931,285
SEED Grant: Calvin Kuo Differentiation of Human Embryonic Stem Cells to Intestinal Fates $554,176
SEED Grant: John Cooke EC regeneration in cerebrovascular ischemia: role of NO $476,995
SEED Grant: Aaron Hsueh Patient-specific cells with nuclear transfer $629,653
SEED Grant: Mark Kay Novel vectors for gene transfer into human ES cells $574,737
SEED Grant: Susan McConnell Optimization of guidance response in human embryonic stem cell derived midbrain dopaminergic neurons in development and disease $608,265
SEED Grant: Phillip Yang In Vivo Molecular Magnetic Resonance Imaging of Human Embryonic Stem Cells in Murine Model of Myocardial Infarction $629,952
SEED Grant: Joanna Wysocka Role of Chromatin Modifiers in Regulating Human Embryonic Stem Cell Pluripotency $629,952
SEED Grant: Joseph Wu In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity $623,634
SEED Grant: Kenneth Weinberg Embryonic stem cell-derived thymic epithelial cells $628,793
SEED Grant: Thomas Wandless Reprogramming Differentiated Human Cells to a Pluripotent State $380,005
Basic Biology I: Helen Blau Molecular Mechanisms of Reprogramming towards Pluripotency $1,408,332
Disease Team Research I: Irving Weissman Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells $18,759,276
Disease Team Research I: Alfred Lane iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa $11,039,208
Shared Labs: Hiromitsu Nakauchi Center for Human Embryonic Stem Cell Research and Education $3,434,600
Shared Labs: Renee Reijo Pera Center for Human Embryonic Stem Cell Research and Education $2,439,590
New Faculty Physician Scientist: Michelle Monje White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” $2,800,536
New Faculty Physician Scientist: Alan Cheng Enhancing hair cell regeneration in mouse and human inner ear $3,091,595
Research Training II: Theo Palmer CIRM Training Program $7,475,333
Tools and Technologies II: Sarah Heilshorn Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
Tools and Technologies II: Brian Rutt Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Tools and Technologies II: Irving Weissman Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,881
Tools and Technologies II: Marius Wernig Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Tools and Technologies II: Michele Calos Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
New Faculty I: Joanna Wysocka Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,374,020
New Faculty I: Karl Deisseroth Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
New Faculty I: Howard Chang Noncoding RNAs in Cell Fate Determination $2,985,894
New Faculty I: Anne Brunet Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
Tools and Technologies II: Theo Palmer Development of small molecule screens for autism using patient-derived iPS cells $1,797,981
Tissue Collection for Disease Modeling: Joseph Wu Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases $1,291,834
Genomics Centers of Excellence Awards (R): Michael Snyder Center of Excellence for Stem Cell Genomics $22,831,963
Disease Team Therapy Development III: Irving Weissman Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $7,672,364
Research Leadership 12: Hiromitsu Nakauchi Generation of functional cells and organs from iPSCs $5,436,307
Disease Team Therapy Development - Research: Joseph Wu Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $19,942,877
Early Translational III: Bertha Chen Autologous iPSC Therapy for Urinary Incontinence $5,025,428
Basic Biology V: Gary Steinberg Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
Basic Biology V: Marius Wernig Mechanisms of human induced neuronal cell reprogramming $1,178,370
Early Translational III: Joseph Wu Heart Repair with Human Tissue Engineered Myocardium $4,397,241
Major Facilities: John Hennessy Stanford SIM1 Building $43,578,000
Basic Biology V: Helen Blau Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
Disease Team Planning: Thomas Rando Stem Cell Therapy for Muscular Dystrophy $0
Disease Team Planning: Robert Robbins {REDACTED} Cardiovascular Regenerative Team $25,119
Tools and Technologies I: Helen Blau Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells $949,608
Disease Team Therapy Planning I: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $90,147
Basic Biology V: Xinnan Wang Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Tissue Collection for Disease Modeling: Joachim Hallmayer Induced pluripotent stem cells from children with autism spectrum disorders $530,265
Creativity Awards: Paul Utz [REDACTED] Program: Stem Cell & Developmental Biology Research Internships $273,201
Disease Team Therapy Development - Research: Judith Shizuru A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants $19,068,382
Early Translational III: Helen Blau Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients $1,825,920
Training Grant I-1: Michael Longaker Stanford CIRM Training Program $3,035,282
Disease Team Therapy Planning I: Robert Robbins Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure $73,030
Disease Team Therapy Planning I: Albert Wong Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma $109,750
Early Translational IV: Michele Calos Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
Total:
$298,318,035.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine